Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.36 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | MMP9 | P14780 | 3/20 | 0.36 |
| ▸ | CMA1 | P23946 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3050428 | 1.00 | HDAC8 (0.39) | HDAC8MMP2CA2MCL1ELANE | |
| SCHEMBL4449192 | 1.00 | HDAC8 (0.39) | HDAC8MMP2CA2MCL1ELANE | |
| SCHEMBL3372052 | 0.90 | ELANE (0.42) | MMP2MCL1ELANE | |
| SCHEMBL10221213 | 0.90 | ELANE (0.42) | MMP2MCL1ELANE | |
| SCHEMBL15483922 | 0.90 | ELANE (0.42) | MMP2MCL1ELANE | |
| SCHEMBL15258574 | 0.90 | ELANE (0.42) | MMP2MCL1ELANE | |
| SCHEMBL12864433 | 0.85 | MMP2 (0.39) | MMP2MCL1MMP9 | |
| SCHEMBL13757878 | 0.84 | AAK1 (0.46) | MMP2MCL1MMP9 | |
| SCHEMBL3372755 | 0.84 | AAK1 (0.46) | MMP2MCL1MMP9 | |
| SCHEMBL3402189 | 0.83 | NR1H2 (0.44) | MMP2MCL1MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100204159-A1 | ORGANIC COMPOUNDS AND THEIR USES | NOVARTIS AG (CH) | 2010-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204159-A1 | ORGANIC COMPOUNDS AND THEIR USES | OAT, OTC, AOX1 | HDAC8 2060/4885MMP2 1771/4885CA2 1716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.